Sun Pharma News

Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement with Celgene Corporation (Celgene), a wholly-owned subsidiary of Bristol Myers Squibb, to resolve the patent litigation regarding submission of an Abbreviated ...

Amid strong global cues, Indian indices in line with their Asian peers opened higher in trade on May 10, 2021 and continue to trade firm in the afternoon session. At the time of writing this report, Nifty was up 123 points ...

2020 has been a dramatic year even for the stock markets. From the sharp drop seen in March amid the peak of the COVID-19 panic, stocks have recovered gradually causing benchmark indices to hit new all-time highs as the year comes ...

Pharma has been among the best performing sectors in 2020, due to anticipation on reporting higher revenue amid the pandemic. In a once in a century kind of health crisis, the pharma industry in India, which is the largest provider of ...

On Friday, Sun Pharmaceutical Industries reported a consolidated net loss of Rs 1,655.60 crore for the June-ended quarter, when compared with a profit of Rs 1,387.48 crore a year ago. Its revenue from operations stood at Rs 7,467.19 crore, which were ...

On Friday, shares of Sun Pharmaceutical Industries Limited rose 4 percent to Rs 497.80 in early trade after its US subsidiary, Taro Pharma reached a settlement agreement with the US Department of Justice (DoJ), Antitrust and Civil divisions to pay $205.7 ...

On Wednesday, Sun Pharmaceutical Industries reported a 37.1 percent decline in consolidated profit of Rs 399.8 crore for the March ended quarter due to a one-time loss of Rs 260.6 crore. The company wrote an amount of Rs 104.28 crore, including ...